Review: taking Abilify and Morphine together


Summary

Drug interactions are reported among people who take Abilify and Morphine together. This review analyzes the effectiveness and drug interactions between Abilify and Morphine. It is created by eHealthMe based on reports of 246 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Abilify and Morphine >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Abilify

Abilify has active ingredients of aripiprazole. It is often used in bipolar disorder. (latest outcomes from Abilify 29,789 users)

Morphine

Morphine has active ingredients of morphine sulfate. It is often used in pain. (latest outcomes from Morphine 48,362 users)

On Jul, 28, 2016

246 people who take Abilify, Morphine are studied.


Number of reports submitted per year:

Abilify and Morphine drug interactions.

Drug effectiveness over time:

Abilify:
  • < 1 month: 66.0% - (2 of 3 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 100.0% - (1 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 2 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 1 people)
  • 10+ years: 0.0% - (0 of 1 people)
  • not specified: 0.0% - (0 of 0 people)
Morphine:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 2 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 100.0% - (1 of 1 people)
  • 2 - 5 years: 100.0% - (3 of 3 people)
  • 5 - 10 years: 0.0% - (0 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Abilify:
  • female: 20.0% - (1 of 5 people)
  • male: 66.0% - (2 of 3 people)
Morphine:
  • female: 40.0% - (2 of 5 people)
  • male: 66.0% - (2 of 3 people)

Drug effectiveness by age:

Abilify:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 0.0% - (0 of 2 people)
  • 50-59: 0.0% - (0 of 2 people)
  • 60+: 100.0% - (2 of 2 people)
Morphine:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 100.0% - (1 of 1 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 0.0% - (0 of 2 people)
  • 50-59: 50.0% - (1 of 2 people)
  • 60+: 100.0% - (2 of 2 people)

Most common drug interactions over time *:

< 1 month:
  • granulocytopenia
  • pancytopenia
  • pyrexia
  • renal failure acute
  • blood pressure increased
  • decreased appetite
  • disorientation
  • double vision
  • face oedema
  • haemoglobin decreased
1 - 6 months:
  • decreased appetite
  • haemoglobin decreased
  • pyrexia
  • neutropenia
  • pneumonia
  • neutrophil count decreased
  • sepsis
  • agitation
  • anxiety
  • white blood cell count decreased
6 - 12 months:
  • sudden cardiac death
  • fatigue
1 - 2 years:
  • death
  • dehydration
  • rhabdomyolysis
  • sepsis
2 - 5 years:
  • disorientation
  • double vision
  • drug ineffective
  • bad breath
10+ years:
  • bad breath
not specified:
  • pain
  • anxiety
  • chest pain
  • back pain
  • fall
  • osteonecrosis of jaw
  • pain in extremity
  • hypertension
  • metastases to bone
  • spinal osteoarthritis

Most common drug interactions by gender *:

female:
  • pain
  • anxiety
  • hypertension
  • back pain
  • osteonecrosis of jaw
  • pain in extremity
  • urinary tract infection
  • anaemia
  • chest pain
  • depression
male:
  • chest pain
  • fall
  • metastases to bone
  • type 2 diabetes mellitus
  • neoplasm malignant
  • diabetes mellitus
  • anxiety
  • pain
  • dyspnoea
  • confusional state

Most common drug interactions by age *:

10-19:
  • death
  • cardio-respiratory arrest
  • apnoea
  • cardiac arrest
  • headache
  • hepatosplenomegaly
  • pain in jaw
  • pulmonary oedema
  • pyrexia
  • respiratory arrest
20-29:
  • asthma
  • depression
  • drug effect decreased
  • maternal exposure during pregnancy
  • multiple sclerosis
  • cholecystitis chronic
  • drug ineffective
  • fall
  • pancreatitis
  • abdominal pain
30-39:
  • abdominal pain
  • chest pain
  • anxiety
  • tooth abscess
  • confusional state
  • constipation
  • diarrhoea
  • nausea
  • pain
  • vomiting
40-49:
  • diabetes mellitus
  • humerus fracture
  • pulmonary haemorrhage
  • pulmonary embolism
  • rectal haemorrhage
  • type 2 diabetes mellitus
  • akathisia
  • agitation
  • arthralgia
  • blood cholesterol increased
50-59:
  • platelet count decreased
  • accidental overdose
  • liver injury
  • fall
  • metastases to bone
  • neoplasm malignant
  • pyrexia
  • nausea
  • diarrhoea
  • unresponsive to stimuli
60+:
  • fall
  • pain
  • anxiety
  • back pain
  • pain in extremity
  • oedema peripheral
  • osteonecrosis of jaw
  • chest pain
  • cellulitis
  • depression

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Abilify and Morphine?

Can you answer these questions?

More questions for: Abilify, Morphine

You may be interested in these reviews

More reviews for: Abilify, Morphine

On eHealthMe, Abilify (aripiprazole) is often used to treat bipolar disorder. Morphine (morphine sulfate) is often used to treat pain. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.